ReviewNuclear medicine and biology2017
Tactics for preclinical validation of receptor-binding radiotracers.
Review in Nuclear medicine and biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- The [18F] F-PSMA Probe: Chemical Perspectives.Current medicinal chemistry · 2025Review
- Evaluation of [Pharmaceuticals (Basel, Switzerland) · 2024Article
- In vitro evaluation of PET radiotracers for imaging synaptic density, the acetylcholine transporter, AMPA-tarp-γ8 and muscarinic M4 receptors in Alzheimer's disease.American journal of nuclear medicine and molecular imaging · 2024Article
- PET Molecular Imaging in Drug Development: The Imaging and Chemistry Perspective.Frontiers in medicine · 2022Review
- Identification of novel target molecules ofHeliyon · 2021Article
- Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity.Molecular imaging and biology · 2020Article
- Review
- Design, synthesis and evaluation ofNuclear medicine and biology · 2019Article
- Synthesis and Preclinical Evaluation of the First Carbon-11 Labeled PET Tracers Targeting Substance PMolecular pharmaceutics · 2018Article
- Exploring the Metabolism of (+)-[Molecules (Basel, Switzerland) · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
introductionAspects of radiopharmaceutical development are illustrated through preclinical studies of [
methodsSyntheses of E-IA-BF-PE-PIPZE and [
resultsE-IA-BF-PE-PIPZE exhibited high affinity and selectivity for σ
conclusionsSubstitution of dihydrobenzofuranylethyl for dimethoxyphenethyl increased radioligand affinity for σ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.